U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07273760) titled 'VedAryo(R) (Vedolizumab) Effectiveness and Safety Evaluation' on Nov. 25.
Brief Summary: The aim of this observational study is to evaluate Effectiveness and safety of VedAryo(R) (Vedolizumab) in male or female participants with clinical diagnosis of Inflammatory Bowel Disease. The main questions are aim to answer:
1. Is VedAryo(R) (Vedolizumab) effective in the treatment of Inflammatory Bowel Disease?
2. Is VedAryo(R) (Vedolizumab) safe in the treatment of Inflammatory Bowel Disease?
In this study, there is no comparison group. Participants received VedAryo(R) (Vedolizumab)
Study Start Date: July 16, 2023
Study Type: OBSERVATI...